Leading CDMO is granted both the WorldStar Award for Vetter-Ject® and a 2016 CMO Leadership Award.
The World Packaging Organization (WPO) has awarded Vetter, a leading contract manufacturing and development organization (CDMO), the WorldStar Award 2016 for its syringe closure system Vetter-Ject®. The WorldStar competition is one of the major events of the WPO, and its award represents the pre-eminent international award in packaging. Vetter has now won four internationally recognized awards for a product only released in July 2015. Two of the awards, won prior to the products launch, include the IF Design Award, and the Red Dot Design Award. Recently, Vetter-Ject® won the “German Packaging Award 2015”.At the same time, Vetter is proud to have also been awarded a CMO Leadership Award 2016 in four categories.
The WorldStar competition is open to any pack or packaging material that has won a recognized or domestic international award related to packaging in either 2014 or 2015. Winning of the German Packaging Award 2015 assured Vetter’s submission to the WorldStar competition. Representatives from 19 packaging associations judged 293 projects entered into the competition from 35 countries. The judging session took place over 2 days in October, 2015 as part of the 95th WPO Board Meeting activities. Vetter had previously won the WorldStar award in 1998 for the Vetter Lyo-Ject® dual chamber syringe.
“The winning of this award,certainly one of the most prestigious in the field of global packaging, is very gratifying to Vetter, and yet another affirmation of the value that Vetter-Ject® brings to the biopharmaceutical industry,” said Dr. Claus Feussner, Senior Vice President, Vetter Development Service. “The three awards we had already received, combined with the WorldStar Award, are a validation of the novel design and technological advances of Vetter-Ject®.” Since its introduction in July, Vetter has had positive feedback both from the market and our customers about this system.
Vetter-Ject®: More Options for Filling Highly Sensitive Compounds
Pharmaceutical and biotech companies are increasingly developing drugs that incorporate sensitive and complex compounds. Administering these drugs requires an injection system that can be used flexibly while being safe and simple to handle. Vetter-Ject® is such a system, consisting of a needle hub and a needle shield. Due to the baked-in siliconization process for the glass barrel, less silicon oil than commonly used is necessary, making Vetter-Ject® particularly suitable for silicone-sensitive drug products. The silicon content of the syringe can also be adjusted according to the requirements of the customer. Thus, the amount of silicon used; as well as the related particle load, can be reduced by up to 80% when compared to the standard siliconization process applied to conventional syringe systems.
Vetter-Ject® is ready-to-use with an integrated needle that is simple to handle and user-friendly. The tamper-evident closure enables that any attempt at opening of the closure system will be immediately and permanently visible to the naked eye. Vetter-Ject®can be used with a wide range of primary packaging options like different stoppers and glass barrels, which can be customized according to the needs of the drug product.
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
